Academic professor UCLouvain
Head of Department,
Department of Rheumatology, UCL Cliniques Universitaires Saint-Luc, Brussels, Belgium
Professor Patrick Durez was trained in rheumatology and rehabilitation, and has spent 1 year in immunology, molecular biology research and studying animal models of inflammation. He is involved in the clinical research program at UCL Cliniques Universitaires Saint-Luc and is responsible for the arthritis clinic at this site.
Professor Durez has conducted many trials on biologics in early, established and refractory RA and has published, as an author or co-author, more than 166 research papers in peer-reviewed journals and has an h-index of 47. He is also developing multidisciplinary projects to establish total care in RA and is in demand as a lecturer on RA for general practitioners and specialists. He is also involved in the support of the patient association in Belgium. He is an active EULAR (quality of care committee, Synovitis study group) and SRBR member (executive and past president). He is an expert member of the federal health council. He has received the Liliane and Suzanne Chermanne Prize from the Royal Belgian Academy of Medicine. He is responsible of the Rheumatology department and the pole Reuma Research at UCLouvain.
Professor chair, consultant, MD, PhD
Deputy head of department for research
Dept of Rheumatology, Aarhus University Hospital
Dept of Clinical Medicine, Aarhus University
Palle Juul-Jensens Boulevard 99, E302
DK-8200 Aarhus N, Denmark
Dzenan Masic
Rheumatologist, PhD, MD.
Department of Rheumatology, Aarhus University Hospital
Department of Clinical Medicine, Aarhus University
Morten Böttcher
Professor, Cardiologist, PhD
Cardiac Imaging Center, University Clinical for Cardiovascular Research
Department of Clinical Medicine, Aarhus University
Bjarne Linde Nørgaard
Professor, Cardiologist, PhD
Department of Cardiology, Aarhus University Hospital
Department of Clinical Medicine, Aarhus University
Professor Hauge has extensive experience as consulting rheumatologist and principal investigator of clinical rheumatology research mainly in arthritis, giant cell arteritis, and cardiovascular comorbidity. She has supervised more than 20 PhD-students and postdocs, reviewed more than 30 PhD theses, published more than 175 scientific papers, edited Danish reference textbooks, and reviewed several national and international grant applications. She has administrative experience as chair clinical professor and deputy head of department for research, Aarhus University, and as head of department at Aarhus University Hospital, Denmark. She has been involved in the Danish Rheumatism Association for more than 10 years and has received the prestigious Queen Ingrid Research Award.
Professor of Medicine
David Geffen School of Medicine at UCLA
Chief, Division of Rheumatology
Harbor-UCLA Medical Center
The Lundquist Institute for Biomedical Innovation
Torrance, CA 90502
Sarah R Ormseth PhD
Harbor-UCLA Medical Center
The Lundquist Institute for Biomedical Innovation
Torrance, CA 90502
Viet L Bui, MD, PhD
Assistant Professor of Medicine
Harbor-UCLA Medical Center
The Lundquist Institute for Biomedical Innovation
Torrance, CA 90502
Dr Karpouzas is a professor of Medicine at the David Geffen School of Medicine at UCLA, Chief of the Division of Rheumatology at Harbor-UCLA Medical Center and a clinical investigator at the Lundquist Institute for Biomedical Innovation. He is directly involved in clinical inpatient and outpatient care at UCLA for the past 24 years. He heads the Rheumatology clinical trials center at Harbor-UCLA. His research interests include atherosclerotic cardiovascular disease in Rheumatoid arthritis and clinical outcomes disparities in Hispanic patients with rheumatoid arthritis. Over the past 10 years, Dr Karpouzas and his team have studied differences in coronary atherosclerosis burden, plaque vulnerability, progression and clinical ASCVD events in a case/control cohort of 150 RA patients without cardiovascular disease and 150 age, gender and geographic controls without RA established at Harbor-UCLA. They have identified and characterized biomarkers of latent atherosclerosis development and progression, validated their clinical utility and proposed an algorithm for noninvasive coronary atherosclerosis screening and surveillance in patients with RA. They characterized anatomically and physiologically the nuanced relationships of blood lipids and obesity with cardiovascular risk in RA and studied the mechanistic effects of bDMARDs and statin therapies on coronary plaque trajectory and cholesterol metabolism (onloading to and efflux from) arterial wall macrophages, associated with their clinical benefit.
Director
Honorary Professor:
Visiting Professor:
George Kitas MD, PhD, FRCP qualified in Greece in 1985, pursued PhD studies followed by clinical training in Birmingham, UK and was appointed Consultant Rheumatologist at the Dudley Group NHS Foundation Trust (Teaching) in 1995, where he was Head of Rheumatology, Clinical Director and R&D Director, until his retirement in 2023. From 2011 he has also been Director of the Centre for the Investigation and Management of Rheumatic Diseases at “Hygeia” Hospital in Athens, Greece. He is Professor of Clinical Rheumatology at the “versus Arthritis” Centre for Epidemiology, Manchester University, of Behavioural Rheumatology at Birmingham University, and of Rheumatology, Musculoskeletal Health and Exercise at Wolverhampton University. He is Chief Editor of the Mediterranean Journal of Rheumatology, has been editorial board member of 6 international journals, expert reviewer for more than 60 international journals, and evaluator for funding bodies and the quality assessment agencies for higher education and research of several countries, including the UK, France, Ireland, Holland, Switzerland, Greece, Italy, Spain, Hong Kong and South Africa. He leads the “Rheumatoid Arthritis Co-morbidity Research Group”, has supervised more than 25 MDs and PhDs and has authored more than 600 peer-reviewed original publications and book chapters (current h index 98, >40.000 citations), the majority in the field of cardiovascular comorbidity of rheumatoid arthritis. He has received research grants from multiple sources, including the Medical Research Council, “versus Arthritis”, British Heart Foundation and the pharmaceutical industry. He is/was Chief Investigator of TRACE RA, the largest Academically-led multicentre prospective RCT in RA in the World, founding member of the multidisciplinary West Midlands Rheumatology Forum and the community-based Birmingham Arthritis Resource Centre, Chairman of the West Midlands Rheumatology Services and Training Committee, Regional Specialty Advisor and Associate International Director (Europe) of the Royal College of Physicians of London, member of the British Society for Rheumatology (BSR) Council, vice-chair of the BSR Heberden Committee, convenor of the BSR Cardiovascular co-morbidity Special Interest Group, member of the EULAR task force on cardiovascular risk management in rheumatic diseases, member of the clinical advisory committee of the National Rheumatoid Arthritis Society in the UK and Chair of the “National Action Plan for Rheumatology” in Greece. He has been granted several national and international awards, including bronze and silver Clinical Excellence Awards in the UK, honorary doctorates at the Universities of Thessaly and Patras, Visiting Professorships at the Universities of Athens and Thessaloniki in Greece, the “Boland” Visiting Professorship of Rheumatology at the Mayo Clinic, USA, the “Skou” Honorary Professorship at the University of Aarhus, Denmark, as well as a scientific achievement award by the Academy of Athens.
Professor of Medicine, Consultant, Director of Inflammatory arthritis group, Division of rheumatology, Mayo Clinic, Rochester, MN; consultant in the Division of Epidemiology, Mayo Clinic, Rochester, MN (Joint appointment)
Educational Background: Ivanovo State Medical Academy – MD, Russian Academy of Medical Sciences – PhD (Pathophysiology), Fulbright scholar in Epidemiology of rheumatic diseases, Mayo Clinic, MN, USA, Clinical Investigator program: Internal Medicine Residency and Rheumatology Fellowship, Mayo Clinic, MN, USA
Dr. Elena Myasoedova is a Professor of Medicine, a practicing clinician-rheumatologist and an NIH R01-funded clinical researcher with over 15 years of experience in clinical outcomes research with a focus on rheumatoid arthritis and individualized medicine. Dr. Myasoedova is Staff Consultant, Director of Inflammatory arthritis group, a Vice Chair of Research at the Division of Rheumatology and an Associate Chair of Research in the Department of Medicine, Mayo Clinic, Rochester, MN. She holds a joint appointment in the Division of Epidemiology, Mayo Clinic, Rochester, MN. Dr. Myasoedova is an active member of the ACR (Scientific Advisory Council of the RRF, Clinical Abstract Selection Committee of the ACR) and EULAR (Big Data Study Group).
The overriding theme in Dr. Myasoedova’s research portfolio is understanding of RA epidemiology and studying the effects of systemic inflammation on clinical outcomes in RA. She has published a series of landmark studies uniquely showing a decline in lipid levels before the onset of RA and for the first time defining the concept of the “lipid paradox” in RA, i.e. a paradoxical association between low serum cholesterol levels, inflammation and increases risk of CVD in patients with RA. Dr. Myasoedova et al. were one of the first to show the role of flares and remissions in the risk of CVD in RA, informing later studies of CVD benefits associated with tight inflammation control and improved flare management in patients with RA. In a series of longitudinal population-based retrospective cohort studies, Dr. Myasoedova et al. showed that following decades of increased CVD risk in RA, there is a decline incidence of myocardial infarction and overall CVD mortality, but not heart failure or stroke, in RA, following advances in RA management and improved control of RA disease activity in the new millennium.
Dr. Elena Joerns, Assistant Professor, Mayo Clinic, MN
Head of Heart Failure, Department of Cardiology, Aarhus University Hospital
Palle Juul Jensens Boulevard 99, 8200 Aarhus N
Telephone: 40142493
Email: bbl@skejby.rm.dk
Dr. Løgstrup is a consultant cardiologist, the founder and the leader of the heart failure section at Aarhus University Hospital. Dr. Løgstrup is associate professor at Aarhus University. He is a regular reviewer for several international rheumatology and cardiology journals. He has published more than 80 original publications in peer-reviewed journals, book chapters and conference abstracts.
Dr. Løgstrup´s research has focused on the epidemiology of rheumatic diseases, with a special interest in rheumatoid arthritis and particularly the associated cardiovascular disease risk in person with rheumatoid arthritis.
Additional Professor, Department of Clinical Immunology and Rheumatology,
Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow-226014, India
Email: durgapmisra@gmail.com; dpmisra@sgpgi.ac.in
Dr Durga Prasanna Misra completed his undergraduate medical training at Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, where he was the recipient of numerous awards (9 institute medals/ prizes, including Dr. S. Lakshmanan Memorial Endowment Prize for Best Student of Pre-final year M.B.B.S Course and Dr. V. Murali Memorial Endowment Prize in Medicine) and secured distinction (> 75% marks) in 11 subjects. Subsequently, after completing postgraduate training in General Medicine at Sriram Chandra Bhanja (SCB) Medical College, Cuttack, and senior residency in Clinical Immunology and Rheumatology at AIIMS, New Delhi, he completed his DM in Clinical Immunology from SGPGIMS, Lucknow. After a year of working as Assistant Professor at JIPMER, Puducherry, he returned to his parent institution to join the department as an Assistant Professor in 2017 (now an Additional Professor since 2023). Dr Misra's areas of research interest include vasculitis (particularly Takayasu arteritis), endothelial biology and cardiovascular risk in rheumatic diseases, epidemiology of rheumatic diseases, as well as scientific writing and editing. He has received extramural research support from the Indian Rheumatology Association, the Indian Council of Medical Research, and the Department of Science and Technology, India. He has published more than 290 papers in peer reviewed journals and more than 20 textbook chapters. His papers have been cited more than 5000 times, with an h index of 37 and i10 index of 134.
Departamento de Immunologia Y Reumatologia ( Immunology and Rheumatology Department)
Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán
Work Address: Vasco De Quiroga N°15,Colonia Belisario Dominguéz, Sección XVI, CP: 14080,Tlalpan, Mexico City, Mexico
Date and Place of Birth: September 2, 1965, Bilbao, Spain.
Home Address: Montaña 161, casa 4, Colonia: Jardines del Pedregal de San Ángel, CP:04500, Coyoacán, CDMX, México.
Home Phone: (5255) 51356844/45.
Work Phone: (5255) 55734111.
E-mail: virtichu@gmail.com
EDUCATION
LABOR EXPERIENCE
HONORS AND AWARDS
Radboud University Medical Centre
Nijmegen, The Netherlands
Piet van Riel has been principle investigator at the Scientific Institute for Quality of Healthcare at the Radboud University Medical Centre, Nijmegen, The Netherlands, Head of the Rheumatology Department and Director and consulting rheumatologist at Bernhoven, Uden, The Netherlands. In November 2019 he retired, currently he is still doing clinical research mainly in the field of Quality Improvement of rheumatology practices by benchmarking structured and unstructured data collected with help of Artificial intelligence. In addition to that he is working two days a week as a consultant at the Rugpoli in the Netherlands.
After graduating in medicine from the Catholic University of Nijmegen in 1978, Piet van Riel trained in internal medicine at St Radboud Hospital, Nijmegen. In 1983, he completed his PhD thesis and went on to receive rheumatology training at the Academic Hospital, Nijmegen. From 1984 until January 2014 he was respectively stafmember, deputy head and head of the department of Rheumatology at the Radboud University Medical Centre . In January 2014 he was asked to start a new, state of the art, department of Rheumatology in Bernhoven, Uden. At this department innovative management strategies for patients with (non)inflammatory rheumatic conditions with the emphasis on patient self management are implemented and evaluated in cooperation with the Scientific Institute for Quality of healthcare of the Radboud University Medical Centre.
Piet van Riel is an active member of many professional societies, including the Dutch Society of Rheumatology, of which he was Chairman from 2003 to 2009, the American College of Rheumatology and the British Society of Rheumatology. From 1999 to 2003 he was Chairman of the EULAR Standing Committee for International Clinical Studies including Therapeutic Trials. In 2013 he founded together with Anne Grete Semb, Sherine Gabriel and George Kitas the ATACC-RA consortium to do cardiovascular research in Inflammatory Rheumatic Diseases.
Professor van Riel’s research interests include clinical research in rheumatology, clinical pharmacology and clinimetrics. He is called the (grand)father of the DAS28 and the EULAR response criteria which he developed with his team in the late eighties. He is on the editorial board of a number of journals and has authored or co-authored several books and over 800 international publications. Currently is h-index is 112 with over 61.000 citations.
Professor of Medicine
Head, Division of Rheumatology
Department of Medicine & Therapeutics
The Chinese University of Hong Kong
Hong Kong
Email: lstam@cuhk.edu.hk
Prof Ho SO
Assistant Professor
Division of Rheumatology
Department of Medicine & Therapeutics
The Chinese University of Hong Kong
Lai-Shan Tam, MD, is division Head and Professor in the Division of Rheumatology within the Department of Medicine and Therapeutics at The Chinese University of Hong Kong (CUHK). She was the Asia Pacific League of Associations for Rheumatology (APLAR) Vice President (from 2014 to 2016), Chairperson of the APLAR International Affairs Committee (from 2012 to 2021), Center of Excellence committee and the APLAR Academy coordinator (since 2021). Professor Tam was a member of the American College of Rheumatology (ACR) International Task Force Subcommittee (2014), the ACR Membership Task Force subcommittee (2015), and the European League Against Rheumatism (EULAR) Programme Committee (from 2016 to 2019). She has also been a EULAR honorary member since 2019. She serves as an Associate Editor for the International Journal of Rheumatic Diseases and Arthritis Research & Therapy, and she is an international advisory board member of The Lancet Rheumatology. She is the first author or co-author of over 280 articles published in major rheumatology journals.
Professor Tam’s research interests include premature atherosclerosis and bone loss in patients with rheumatic diseases.
